ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF

ClinicalTrials.gov ID: NCT02786836

Public ClinicalTrials.gov record NCT02786836. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

13C-Methacetin Breath Test for the Prediction of Outcome in in Acute Liver Injury or Acute Liver Failure

Study identification

NCT ID
NCT02786836
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
University of Texas Southwestern Medical Center
Other
Enrollment
76 participants

Conditions and interventions

Interventions

  • 13C-Methacetin Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 9, 2016
Primary completion
Sep 17, 2019
Completion
Sep 17, 2019
Last update posted
Dec 21, 2020

2016 – 2019

United States locations

U.S. sites
11
U.S. states
11
U.S. cities
11
Facility City State ZIP Site status
University of Alabama, Birmingham Birmingham Alabama 35294
University of California, San Francisco San Francisco California 94143
Yale University School of Medicine New Haven Connecticut 06520
Northwestern University Chicago Illinois 60611
University of Kansas Medical Center Kansas City Kansas 66160
University of Michigan Ann Arbor Michigan 48109
Ohio State University Medical Center Columbus Ohio 43210
Medical University of South Carolina Charleston South Carolina 29425
UT Southwestern Medical Center at Dallas Dallas Texas 75390-8887
VCU Medical Center Richmond Virginia 23298
University of Washington Medical Center Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02786836, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 21, 2020 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02786836 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →